High Blood Pressure (Hypertension)
Hypertension, or high blood pressure, is a common condition where the force of the blood against the artery walls is too high, which can lead to serious health issues if left untreated.
We are exploring whether a new combination of medications can help people with uncontrolled high blood pressure achieve better control. This study will compare different treatment strategies to find the most effective approach.
Health conditions and diseases that the clinical trial is designed to study and treat.
Hypertension, or high blood pressure, is a common condition where the force of the blood against the artery walls is too high, which can lead to serious health issues if left untreated.
Overpressure refers to a condition where blood pressure is higher than normal, which can lead to various cardiovascular issues if not managed properly.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.
Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.